Liminal BioSciences Inc. (LMNL)の価格はいくらですか

Liminal BioSciences Inc. (LMNL)の価格は$8.50です

Liminal BioSciences Inc. (LMNL)の時価総額は何ですか

Liminal BioSciences Inc. (LMNL)の時価総額は$719.10Kです

Liminal BioSciences Inc.（LMNL）の株価履歴

Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.

年	パフォーマンス
2023	112.62%
2022	-61.46%
2021	-76.57%
2020	-35.75%
2019	-97.45%
2018	-73.89%
2017	-28.49%
2016	-38.09%
2015	36.88%
2014	102.93%
2013	334.33%
2012	40.83%
2011	23.59%
2010	-34.41%
2009	0.00%

年

パフォーマンス

2023

112.62%

2022

-61.46%

2021

-76.57%

2020

-35.75%

2019

-97.45%

2018

-73.89%

2017

-28.49%

2016

-38.09%

2015

36.88%

2014

102.93%

2013

334.33%

2012

40.83%

2011

23.59%

2010

-34.41%

2009

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$507.52	30.03%	US
Argenx SE ARGX.US	$847.62	29.92%	NL
Lonza Group AG LONN.SW	$731.69	7.13%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.40%	KR
UCB S.A. UCB.BR	$251.82	11.25%	BE

企業

株価

変化率 1年%

国